Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.
OBJECTIVES: To determine the prevalence, determinants ofpositivity, and clinical utility of serum cryptococcal polysaccharide (CPS) antigen testing among HIV-infected patients in 2004 in Cambodia, an area highly endemic for cryptococcosis. METHODS: All HIV-infected patients with a CD4+ count &l...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Journal article |
| Lenguaje: | English |
| Publicado: |
2007
|
| _version_ | 1826263242333224960 |
|---|---|
| author | Micol, R Lortholary, O Sar, B Laureillard, D Ngeth, C Dousset, J Chanroeun, H Ferradini, L Guerin, P Dromer, F Fontanet, A |
| author_facet | Micol, R Lortholary, O Sar, B Laureillard, D Ngeth, C Dousset, J Chanroeun, H Ferradini, L Guerin, P Dromer, F Fontanet, A |
| author_sort | Micol, R |
| collection | OXFORD |
| description | OBJECTIVES: To determine the prevalence, determinants ofpositivity, and clinical utility of serum cryptococcal polysaccharide (CPS) antigen testing among HIV-infected patients in 2004 in Cambodia, an area highly endemic for cryptococcosis. METHODS: All HIV-infected patients with a CD4+ count <200 cells/mm3 attending 1 of 2 Phnom Penh hospitals for the first time were systematically screened for serum CPS. Patients with positive test results were further investigated to identify those with cryptococcal meningitis (CM), pulmonary cryptococcosis, or isolated positive cryptococcal antigenemia (IPCA). RESULTS: The median (interquartile range [IQR]) CD4+ count of 327 enrolled patients was 24 (IQR: 8 to 65) cells/mm3. The prevalence of cryptococcal infection was 59 (18.0%) of 327 cases, of which 41 were CM and 10 were IPCA. In the absence of serum CPS detection, 17 (28.8%) of 59 cryptococcal infections would have been missed on the day of consultation. In patients with no specific symptoms of meningoencephalitis, the prevalence of positive serum CPS detection was 32 (10.8%) of 295 cases. Countryside residence (adjusted odds ratio [AOR] = 3.6), headache (AOR = 3.2), body mass index <15.4 kg/m2 (AOR = 3.4), CD4+ count <50 cells/mm3 (AOR = 4.0), and male gender (marginally, AOR = 2.1) were all independently associated with a positive test results. CONCLUSION: Serum CPS screening among AIDS patients with a CD4+ count <100 cells/mm3 is useful in areas highly endemic for cryptococcosis, allowing early diagnosis and treatment of this opportunistic infection. |
| first_indexed | 2024-03-06T19:48:37Z |
| format | Journal article |
| id | oxford-uuid:2333e2e1-8519-4725-9dd6-803e7f68f36b |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T19:48:37Z |
| publishDate | 2007 |
| record_format | dspace |
| spelling | oxford-uuid:2333e2e1-8519-4725-9dd6-803e7f68f36b2022-03-26T11:43:00ZPrevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:2333e2e1-8519-4725-9dd6-803e7f68f36bEnglishSymplectic Elements at Oxford2007Micol, RLortholary, OSar, BLaureillard, DNgeth, CDousset, JChanroeun, HFerradini, LGuerin, PDromer, FFontanet, A OBJECTIVES: To determine the prevalence, determinants ofpositivity, and clinical utility of serum cryptococcal polysaccharide (CPS) antigen testing among HIV-infected patients in 2004 in Cambodia, an area highly endemic for cryptococcosis. METHODS: All HIV-infected patients with a CD4+ count <200 cells/mm3 attending 1 of 2 Phnom Penh hospitals for the first time were systematically screened for serum CPS. Patients with positive test results were further investigated to identify those with cryptococcal meningitis (CM), pulmonary cryptococcosis, or isolated positive cryptococcal antigenemia (IPCA). RESULTS: The median (interquartile range [IQR]) CD4+ count of 327 enrolled patients was 24 (IQR: 8 to 65) cells/mm3. The prevalence of cryptococcal infection was 59 (18.0%) of 327 cases, of which 41 were CM and 10 were IPCA. In the absence of serum CPS detection, 17 (28.8%) of 59 cryptococcal infections would have been missed on the day of consultation. In patients with no specific symptoms of meningoencephalitis, the prevalence of positive serum CPS detection was 32 (10.8%) of 295 cases. Countryside residence (adjusted odds ratio [AOR] = 3.6), headache (AOR = 3.2), body mass index <15.4 kg/m2 (AOR = 3.4), CD4+ count <50 cells/mm3 (AOR = 4.0), and male gender (marginally, AOR = 2.1) were all independently associated with a positive test results. CONCLUSION: Serum CPS screening among AIDS patients with a CD4+ count <100 cells/mm3 is useful in areas highly endemic for cryptococcosis, allowing early diagnosis and treatment of this opportunistic infection. |
| spellingShingle | Micol, R Lortholary, O Sar, B Laureillard, D Ngeth, C Dousset, J Chanroeun, H Ferradini, L Guerin, P Dromer, F Fontanet, A Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. |
| title | Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. |
| title_full | Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. |
| title_fullStr | Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. |
| title_full_unstemmed | Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. |
| title_short | Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. |
| title_sort | prevalence determinants of positivity and clinical utility of cryptococcal antigenemia in cambodian hiv infected patients |
| work_keys_str_mv | AT micolr prevalencedeterminantsofpositivityandclinicalutilityofcryptococcalantigenemiaincambodianhivinfectedpatients AT lortholaryo prevalencedeterminantsofpositivityandclinicalutilityofcryptococcalantigenemiaincambodianhivinfectedpatients AT sarb prevalencedeterminantsofpositivityandclinicalutilityofcryptococcalantigenemiaincambodianhivinfectedpatients AT laureillardd prevalencedeterminantsofpositivityandclinicalutilityofcryptococcalantigenemiaincambodianhivinfectedpatients AT ngethc prevalencedeterminantsofpositivityandclinicalutilityofcryptococcalantigenemiaincambodianhivinfectedpatients AT doussetj prevalencedeterminantsofpositivityandclinicalutilityofcryptococcalantigenemiaincambodianhivinfectedpatients AT chanroeunh prevalencedeterminantsofpositivityandclinicalutilityofcryptococcalantigenemiaincambodianhivinfectedpatients AT ferradinil prevalencedeterminantsofpositivityandclinicalutilityofcryptococcalantigenemiaincambodianhivinfectedpatients AT guerinp prevalencedeterminantsofpositivityandclinicalutilityofcryptococcalantigenemiaincambodianhivinfectedpatients AT dromerf prevalencedeterminantsofpositivityandclinicalutilityofcryptococcalantigenemiaincambodianhivinfectedpatients AT fontaneta prevalencedeterminantsofpositivityandclinicalutilityofcryptococcalantigenemiaincambodianhivinfectedpatients |